GLPGF Earnings Reports, EPS & Revenue History
Quarterly EPS and revenue vs. estimates for Lakefront Biotherapeutics. Review beat/miss history, upcoming consensus figures, and earnings call transcripts when available.
EPS and Earnings Announcement
Latest Quarterly EPS
Next Earnings Announcement
Unlock for free
Already registered? Sign in
EPS vs. Estimates
Green band = beat vs estimate · Red band = miss · Lines show actual and consensus EPS.
EPS & Revenue vs. Estimates
Upgrade| Date | EPS Actual | EPS Est. | EPS Diff. |
|---|---|---|---|
May 6, 2026 | 0.24 | -0.94 | +1.18 |
Feb 23, 2026 | 13.94 | -0.13 | +14.07 |
Nov 5, 2025 | -3.59 | -0.48 | -3.11 |
Jul 23, 2025 | — | — | — |
Apr 23, 2025 | — | — | — |
Feb 12, 2025 | — | — | — |
Oct 30, 2024 | — | — | — |
Aug 1, 2024 | — | — | — |
May 2, 2024 | — | — | — |
Feb 22, 2024 | — | — | — |
Sep 29, 2023 | — | — | — |
Jun 29, 2023 | — | — | — |
Mar 31, 2023 | — | — | — |
Feb 23, 2023 | — | — | — |
Nov 3, 2022 | — | — | — |
Aug 4, 2022 | — | — | — |
May 5, 2022 | — | — | — |
Feb 24, 2022 | — | — | — |
Nov 4, 2021 | — | — | — |
Aug 5, 2021 | — | — | — |
May 6, 2021 | — | — | — |
Feb 18, 2021 | — | — | — |
Nov 5, 2020 | — | — | — |
Aug 6, 2020 | — | — | — |
May 6, 2020 | — | — | — |
Feb 20, 2020 | — | — | — |
Oct 24, 2019 | — | — | — |
Jul 25, 2019 | — | — | — |
Apr 25, 2019 | — | — | — |
Feb 21, 2019 | — | — | — |
Oct 24, 2018 | — | — | — |
Aug 2, 2018 | — | — | — |
Apr 25, 2018 | — | — | — |
Feb 22, 2018 | — | — | — |
Oct 30, 2017 | — | — | — |
Jul 28, 2017 | — | — | — |
Apr 27, 2017 | — | — | — |
Jul 29, 2016 | — | — | — |
Apr 28, 2016 | — | — | — |
Mar 3, 2016 | — | — | — |
Nov 13, 2015 | — | — | — |
Earnings Call Transcripts
UpgradeEarnings Call Transcripts Require Subscription
Access to earnings call transcripts and AI-powered summaries is available for Pro, Premium, and Enterprise subscribers.
View Pricing PlansRevenue Breakdown
Want to understand GLPGF's revenue sources? Explore detailed revenue breakdowns by product line and geographic region to see what's driving the company's top line.
View Revenue Breakdown